Načítá se...
Non-Myeloablative Conditioning for Second Hematopoietic Cell Transplantation for Graft Failure in Patients with Non-Malignant Disorders: A prospective study and review of the literature
Allogeneic hematopoietic cell transplantation (HCT) effectively treats seeveral non-malignant disorders (NMD) such as selected lysosomal disorders, cerebral adrenoleukodystrophy, and hemoglobinopathies. However, rates of graft failure (GF) in non-malignant populations exceed those of patients with m...
Uloženo v:
| Vydáno v: | Bone Marrow Transplant |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5604220/ https://ncbi.nlm.nih.gov/pubmed/28092353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.356 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|